Journal
IMMUNOLOGY LETTERS
Volume 83, Issue 2, Pages 77-83Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0165-2478(02)00074-3
Keywords
co-stimulation; B7.1; CD28; CTLA4; immunoglobin
Categories
Ask authors/readers for more resources
Antagonists of the B7 family of co-stimulatory molecules have the potential for altering immune responses therapeutically. To better define the requirements for such inhibitors, we have mapped the binding of an entire panel of blocking antibodies specific for human B7.1. By mutagenesis, each of the residues critical for blocking antibody binding appeared to fall entirely within the N-terminal V-set domain of B7.1. Thus, although antibody-antigen interacting surfaces can be quite large, these results indicate that a relatively small portion of the GFCC'C face of this domain is crucial for further antagonist development. (C) 2002 Published by Elsevier Science B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available